Biotech Giant Amgen Misses Street's Expectations
Amgen ( AMGN ), the world's largest biotechnology company, reported fourth-quarter results that missed Wall Street's expectations, as a 2% increase in sales failed to translate into a stronger bottom line. The quarter was a somewhat expected disappointment , as its adjusted earnings per share decreased 1% to $1.05 per share, below analyst estimates of $1.16 per share, according to Thomson Reuters. Continue reading Biotech Giant Amgen Misses Street's Expectations Biotech Giant Amgen Misses Street's Expectations originally appeared on DailyFinance on Mon, 25 Jan 2010 18:45:00. Filed Under: Earnings , Amgen Permalink | Tweet this! | Comments
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here